HealthInvest Partners AB »

Boston Scientific Corporation shares owned by HealthInvest Partners AB

Quarter-by-quarter ownership of Boston Scientific Corporation (BSX) shares owned by HealthInvest Partners AB from 13F filings

Historical chart of HealthInvest Partners AB investment in Boston Scientific Corporation

Tip: Access up to 7 years of quarterly data

All positions including Boston Scientific Corporation held by HealthInvest Partners AB consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Boston Scientific Corporation by HealthInvest Partners AB

Quarter filed Position value Share count Share price at filing
2024-09-30 $8.9M 106k 83.80
2024-03-31 $5.3M 77k 68.49
2023-12-31 $3.7M 65k 57.81
2022-12-31 $49k 1.1k 46.27

More positions owned by HealthInvest Partners AB

Eli Lilly & Co. (LLY)
UnitedHealth (UNH)
Merck & Co (MRK)
Thermo Fisher Scientific (TMO)
Amgen (AMGN)
Boston Scientific Corporation (BSX)
Abbvie (ABBV)
Stryker Corporation (SYK)
AmerisourceBergen (COR)
Vertex Pharmaceuticals Incorporated (VRTX)
Regeneron Pharmaceuticals (REGN)
Neurocrine Biosciences (NBIX)
Alkermes SHS (ALKS)
Intra Cellular Therapies (ITCI)
Harmony Biosciences Hldgs In (HRMY)

View all positions for HealthInvest Partners AB

Top funds holding Boston Scientific Corporation

Vanguard Group
BlackRock
BlackRock
State Street Corporation
PRIMECAP Management Company
Bank of America Corporation
Geode Capital Management
Jpmorgan Chase & Co
Massachusetts Financial Services
DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt am Main
Capital World Investors
Bollard
Morgan Stanley
Henderson Group
Franklin Resources

View all funds holding Boston Scientific Corporation